These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 2910452

  • 1. Induction of erythroid differentiation of K562 human leukemic cells by herbimycin A, an inhibitor of tyrosine kinase activity.
    Honma Y, Okabe-Kado J, Hozumi M, Uehara Y, Mizuno S.
    Cancer Res; 1989 Jan 15; 49(2):331-4. PubMed ID: 2910452
    [Abstract] [Full Text] [Related]

  • 2. Effects of herbimycin A derivatives on growth and differentiation of K562 human leukemic cells.
    Honma Y, Kasukabe T, Hozumi M, Shibata K, Omura S.
    Anticancer Res; 1992 Jan 15; 12(1):189-92. PubMed ID: 1567167
    [Abstract] [Full Text] [Related]

  • 3. Herbimycin A, an inhibitor of tyrosine kinase, prolongs survival of mice inoculated with myeloid leukemia C1 cells with high expression of v-abl tyrosine kinase.
    Honma Y, Okabe-Kado J, Kasukabe T, Hozumi M, Kodama H, Kajigaya S, Suda T, Miura Y.
    Cancer Res; 1992 Jul 15; 52(14):4017-20. PubMed ID: 1617678
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Herbimycin A accelerates the induction of apoptosis following etoposide treatment or gamma-irradiation of bcr/abl-positive leukaemia cells.
    Riordan FA, Bravery CA, Mengubas K, Ray N, Borthwick NJ, Akbar AN, Hart SM, Hoffbrand AV, Mehta AB, Wickremasinghe RG.
    Oncogene; 1998 Mar 26; 16(12):1533-42. PubMed ID: 9569020
    [Abstract] [Full Text] [Related]

  • 6. Transient activation of Ras-dependent signalling at the early stages of Herbimycin A induced erythroid differentiation of human K562 cells.
    Drobot L, Husak Z, Ilnytska O, Igumentseva N, Oleksyn H, Kusen' S.
    Exp Oncol; 2005 Mar 26; 27(1):31-7. PubMed ID: 15812354
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of phosphotyrosine phosphatase 1B causes resistance in BCR-ABL-positive leukemia cells to the ABL kinase inhibitor STI571.
    Koyama N, Koschmieder S, Tyagi S, Portero-Robles I, Chromic J, Myloch S, Nürnberger H, Rossmanith T, Hofmann WK, Hoelzer D, Ottmann OG.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2025-31. PubMed ID: 16609011
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis.
    Gambacorti-Passerini C, le Coutre P, Mologni L, Fanelli M, Bertazzoli C, Marchesi E, Di Nicola M, Biondi A, Corneo GM, Belotti D, Pogliani E, Lydon NB.
    Blood Cells Mol Dis; 1997 Dec 01; 23(3):380-94. PubMed ID: 9446752
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of herbimycin A, an antagonist of tyrosine kinase, on bcr/abl oncoprotein-associated cell proliferations: abrogative effect on the transformation of murine hematopoietic cells by transfection of a retroviral vector expressing oncoprotein P210bcr/abl and preferential inhibition on Ph1-positive leukemia cell growth.
    Okabe M, Uehara Y, Miyagishima T, Itaya T, Tanaka M, Kuni-Eda Y, Kurosawa M, Miyazaki T.
    Blood; 1992 Sep 01; 80(5):1330-8. PubMed ID: 1515646
    [Abstract] [Full Text] [Related]

  • 13. Ectopic cyclin D1 expression blocks STI571-induced erythroid differentiation of K562 cells.
    Kawano T, Horiguchi-Yamada J, Saito S, Iwase S, Furukawa Y, Kano Y, Yamada H.
    Leuk Res; 2004 Jun 01; 28(6):623-9. PubMed ID: 15120940
    [Abstract] [Full Text] [Related]

  • 14. Apoptosis and erythroid differentiation triggered by Bcr-Abl inhibitors in CML cell lines are fully distinguishable processes that exhibit different sensitivity to caspase inhibition.
    Jacquel A, Colosetti P, Grosso S, Belhacene N, Puissant A, Marchetti S, Breittmayer JP, Auberger P.
    Oncogene; 2007 Apr 12; 26(17):2445-58. PubMed ID: 17043649
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Enhancement by hemin of the sensitivity of K562 human leukemic cells to 1-beta-D-arabinofuranosylcytosine.
    Okabe-Kado J, Hayashi M, Honma Y, Hozumi M.
    Cancer Res; 1986 Mar 12; 46(3):1239-43. PubMed ID: 3455882
    [Abstract] [Full Text] [Related]

  • 17. Accumulation of gamma-globin mRNA and induction of irreversible erythroid differentiation after treatment of CML cell line K562 with new doxorubicin derivatives.
    Szulawska A, Arkusinska J, Czyz M.
    Biochem Pharmacol; 2007 Jan 15; 73(2):175-84. PubMed ID: 17097070
    [Abstract] [Full Text] [Related]

  • 18. Herbimycin A enhances apoptotic effect of chemotherapeutic drugs on K562 cells.
    Ren H, Chen S, Lu D.
    Chin Med J (Engl); 1998 Aug 15; 111(8):678-81. PubMed ID: 11245017
    [Abstract] [Full Text] [Related]

  • 19. c-Jun blocks cell differentiation but not growth inhibition or apoptosis of chronic myelogenous leukemia cells induced by STI571 and by histone deacetylase inhibitors.
    Huang HM, Liu JC.
    J Cell Physiol; 2009 Mar 15; 218(3):568-74. PubMed ID: 19006173
    [Abstract] [Full Text] [Related]

  • 20. Effect of herbimycin A on growth and pp60c-src activity in human colon tumor cell lines.
    Garcia R, Parikh NU, Saya H, Gallick GE.
    Oncogene; 1991 Nov 15; 6(11):1983-9. PubMed ID: 1719464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.